The Long Case For Antares Pharma, Inc. (ATRS)

The Long Case For Antares Pharma, Inc. (ATRS)

Antares Pharma, Inc. (NASDAQ:ATRS) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now trading with a market value of 554.40M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.

Antares Pharma, Inc. (NASDAQ:ATRS) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece […]

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.